At Alien Technology Transfer, we want to turn game-changing ideas into reality. Our unique portfolio of services is tailored to make that happen. From product design to contract manufacturing, our network of partners is geared to support breakthrough technologies at every stage of development. Once groundbreaking projects are ready to enter the market, our clients can benefit from the support of a trusted network of private investors specialised in innovation.
Mobilitech Capital is committed to accelerate the global transition to sustainable, efficient and smart mobility by investing and supporting the journey of phenomenal entrepreneurs in mobility startups. They offer smart capital to game changing innovations with ambitious founders at an early stage.
Faraday Venture Partners is a pan-European Venture Capital firm investing in European early-stage startups via its network of private investors’ Clubs (located in Spain, Germany and Benelux) and own Venture Capital fund since 2011. They invest in and support innovative, ambitious and committed teams with customers on top of their minds, great execution capabilities and a burning ambition to create value and positively impact Society. Their private funding and strategic support (e.g. commercial empowerment, best practices, strategic advice and members & co-investors’ network) is aimed at giving early-stage startups a competitive edge and helping them succeed.
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel. They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcare system. They are investors AND entrepreneurs: As investors, they have funded 45 MedTech companies in the past 28 years. As entrepreneurs, they have founded, built, and exited several successful European MedTech distribution companies.
Inventures Investment Partners (IIP) is a management company that manages the impact venture capital funds, Inventures I and Inventures II. IIP’s mission is to produce attractive financial and social returns. Inventures align their investments with the Sustainable Development Goals (SDGs). In addition to achieving attractive and sustainable financial returns, all of their portfolio companies must contribute in a positive and measurable manner to SDGs achievements. Inventures invests in companies that integrate impact into their core business model and proposition.
Angelini Hive is a venture firm that builds and invests in revolutionary health and wellness companies impacting lives around the world by improving access to care. Angelini Hive invests in growing people and ideas to create sustainable innovation in healthcare.
IAG is the largest network of business angels in Italy, investing time and capital to support the growth of innovative startups. Founded in 2007, it has brought to Italy an investment formula born in the United States that gathers private capitals to finance rounds in companies from four industries: Life Science, Deep Tech, Digital and Fintech.
Primo Ventures brings together an investment team with a solid entrepreneurial track record, supporting new entrepreneurs ready to disrupt businesses and sectors. It focuses on the digital sector with the dedicated Barcamper Ventures Fund and Barcamper Ventures Lazio Fund, while Primo Space Fund is specialised in the new space economy.
LVenture Group SpA is a VC holding and the leading Italian startup accelerator. Since 2013 it has accelerated more than 130 startups, all characterised by high digital innovation and scalability. It provides digital innovators with smart capital, mentorship and a wide network of international partners, investors, corporates, and Institutions as well as a 9,000 sq m Hub in Rome.
Founded by Dr. Shimon Eckhouse, Alon Medtech is an early stage Venture Capital that invests in first-class entrepreneurs to transform innovative medical device ideas into successful companies. Alon Medtech contributes to the creation of unique medical technologies and solutions with the potential to improve the well-being and quality of life of humankind all over the world.
Trendlines is an investment company that invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies to fulfil its mission to improve the human condition. The dedicated Trendlines team brings together a wide-ranging expertise that includes banking, finance, law, R&D, business development, communications, media, and marketing, with the purpose of capitalising on Trendlines’ partnerships with entrepreneurs, investors, strategic players, inventors, and governments.
From product design to contract manufacturing, our network of partners is geared to support breakthrough technologies at every stage of development.
Discover our network of partners